Live Status Check

NCT06086522 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 2:44 PM UTC

NCT06086522 Status Summary

NCT NumberNCT06086522
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment54 participants
Active Locations4 sites in the US
SponsorQualigen Theraputics, Inc.
Last Updated on CT.govMay 1, 2024 (May 1, 2024)

About NCT06086522 Enrollment Status

As of July 13, 2026: Clinical trial NCT06086522 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 4 locations across the United States. The study is sponsored by Qualigen Theraputics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06086522

Is NCT06086522 still recruiting?

Yes, NCT06086522 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06086522 recruiting?

This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06086522?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06086522 status last updated?

The official ClinicalTrials.gov record for NCT06086522 was last updated May 1, 2024 (May 1, 2024). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial